Eyewire+Alcon Launches Clareon TruPlus, Enhanced Design Monofocal and Toric IOLs

Alcon announced the US launch of Clareon TruPlus, a next‑generation monofocal and toric intraocular lens, at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting. The lens expands the Clareon portfolio with an enhanced monofocal design intended to increase depth of focus while preserving distance vision quality.

This announcement is based largely on optical bench data and company‑reported performance. Real‑world outcomes, patient‑reported satisfaction, and comparative clinical data will determine long‑term clinical positioning.

Clinical Considerations

• Clareon TruPlus is positioned as an enhanced monofocal, aiming to improve intermediate vision without introducing multifocal optics.
• According to Alcon, proprietary Opti‑Balance Technology redistributes light energy to extend depth of focus while maintaining distance image quality.
• Bench testing showed improved intermediate simulated visual acuity compared with the Clareon Monofocal and favorable glare and halo profiles versus other enhanced monofocal designs.
• The platform builds on the established Clareon material and design, which surgeons may already use across monofocal, EDOF, and trifocal options.

Practice Applications

• For ophthalmologists: Consider TruPlus as a potential option for patients seeking improved intermediate function without accepting multifocal trade‑offs, pending real‑world outcomes data.
• For optometrists: Prepare to counsel postoperative patients on realistic expectations, especially regarding intermediate vision tasks and spectacle dependence.
• For opticians: Anticipate ongoing need for near correction in many patients, despite enhanced intermediate performance claims.
• Across settings: Monitor upcoming peer‑reviewed clinical studies to understand how TruPlus performs outside bench testing environments.

More in Intraocular Lens (IOL)